Hu K - Search Results

1

Dysregulation of N⁶-methyladenosine regulators predicts poor patient survival in mantle cell lymphoma.

Zhang W, He X, Hu J, Yang P, Liu C, Wang J, An R, Zhen J, Pang M, Hu K, Ke X, Zhang X, Jing H. Zhang W, et al. Among authors: hu j, hu k. Oncol Lett. 2019 Oct;18(4):3682-3690. doi: 10.3892/ol.2019.10708. Epub 2019 Aug 2. Oncol Lett. 2019. PMID: 31516580 Free PMC article.

2

[Changes of pathogens for nosocomial infection of patients with hematological diseases].

Wang JJ, Hu K, Wang ZH, Wang J, Jing HM, Zhao W, Liu Y, Chen YP, Ke XY. Wang JJ, et al. Among authors: hu k. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1031-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 20723323 Chinese.

3

[Analysis of clinical features and prognostic factors in 59 cases of follicular lymphoma].

Zhang W, Wang J, Wan W, Wan WL, Wang JJ, Hu K, Ke XY. Zhang W, et al. Among authors: hu k. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1448-53. doi: 10.7534/j.issn.1009-2137.2013.06.015. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24370027 Chinese.

4

[Clinical observation and long-time follow-up of patients with malignant lymphoma treated with autologous peripheral blood hematopoietic stem cell transplantation].

Hu K, Wang JJ, Zhao W, Tian L, Wan W, Ke XY. Hu K, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1471-6. doi: 10.7534/j.issn.1009-2137.2013.06.019. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24370031 Chinese.

5

[Immunophenotype characteristics of patients with multiple myeloma in different risk stratification].

Hu K, Wang J, Zhu MX, Wang YF, Ke XY. Hu K, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Dec;22(6):1624-7. doi: 10.7534/j.issn.1009-2137.2014.06.023. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25543486 Chinese.

6

Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.

Fu L, Shi J, Hu K, Wang J, Wang W, Ke X. Fu L, et al. Among authors: hu k. Oncotarget. 2015 Apr 10;6(10):8144-54. doi: 10.18632/oncotarget.3519. Oncotarget. 2015. PMID: 25924238 Free PMC article.

7

High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia.

Fu L, Fu H, Tian L, Xu K, Hu K, Wang J, Wang J, Jing H, Shi J, Ke X. Fu L, et al. Among authors: hu k. Oncotarget. 2016 Mar 29;7(13):15828-39. doi: 10.18632/oncotarget.7489. Oncotarget. 2016. PMID: 26910834 Free PMC article.

8

[Analysis of Clinical Feature and Curative Efficacy of 30 Patients with T Cell Lymphoblastic Lymphoma].

Yang P, Zhao W, Jing HM, Hu K, Wan W, Wang JJ, Ke XY. Yang P, et al. Among authors: hu k. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):1056-60. doi: 10.7534/j.issn.1009-2137.2016.04.018. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 27531774 Chinese.

9

High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia.

Fu L, Fu H, Zhou L, Xu K, Pang Y, Hu K, Wang J, Tian L, Liu Y, Wang J, Jing H, Huang W, Ke X, Shi J. Fu L, et al. Among authors: hu k. Sci Rep. 2016 Sep 30;6:34546. doi: 10.1038/srep34546. Sci Rep. 2016. PMID: 27686215 Free PMC article.

10

A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.

Fu L, Shi J, Liu A, Zhou L, Jiang M, Fu H, Xu K, Li D, Deng A, Zhang Q, Pang Y, Guo Y, Hu K, Zhou J, Wang Y, Huang W, Jing Y, Dou L, Wang L, Xu K, Ke X, Nervi C, Li Y, Yu L. Fu L, et al. Among authors: hu k. Int J Cancer. 2017 Feb 1;140(3):653-661. doi: 10.1002/ijc.30481. Epub 2016 Nov 10. Int J Cancer. 2017. PMID: 27770540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,205 results

Search Page

Filters